An oligonucleotide (I100-15) composed of only deoxyguanosine and thymidine was able to inhibit human immunodeficiency virus type-1 (HIV-1) in culture assay systems. I100-15 did not block virus entry into cells but did reduce viral-specific transcripts. As assessed by NMR and polyacrylamide gel methods, I100-15 appears to form a structure in which two stacked guanosine tetrads are connected by three two-base long loops. Structure/activity experiments indicated that formation of intramolecular guanosine tetrads was necessary to achieve maximum antiviral activity. The single deoxyguanosine nucleotide present in each loop was found to be extremely important for the overall antiviral activity. The toxicity of I100-15 was determined to be well above the 50% effective dose (ED) in culture which yielded a high therapeutic index (>100). The addition of a cholesterol moiety to the 3` terminus of I100-15 (I100-23) reduced the ED value to less than 50 nM (from 0.12 µM for I100-15) and increased the duration of viral suppression to greater than 21 days (versus 7-10 days for I100-15) after removal of the drug from infected cell cultures. The favorable therapeutic index of such molecules coupled with the prolonged suppression of HIV-1, suggest that such compounds further warrant investigation as potential therapeutic agents.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				N. Jing, Q. Zhu, P. Yuan, Y. Li, L. Mao, and D. J. Tweardy Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer. Mol. Cancer Ther., February 1, 2006; 5(2): 279 - 286. [Abstract] [Full Text] [PDF]

				D.-S. Lee, K.-E. Jung, C.-H. Yoon, H. Lim, and Y.-S. Bae Newly Designed Six-Membered Azasugar Nucleotide-Containing Phosphorothioate Oligonucleotides as Potent Human Immunodeficiency Virus Type 1 Inhibitors Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4110 - 4120. [Abstract] [Full Text] [PDF]

				B. Sacca, L. Lacroix, and J.-L. Mergny The effect of chemical modifications on the thermal stability of different G-quadruplex-forming oligonucleotides Nucleic Acids Res., February 24, 2005; 33(4): 1182 - 1192. [Abstract] [Full Text] [PDF]

				N. Jing, Y. Li, W. Xiong, W. Sha, L. Jing, and D. J. Tweardy G-Quartet Oligonucleotides: A New Class of Signal Transducer and Activator of Transcription 3 Inhibitors That Suppresses Growth of Prostate and Breast Tumors through Induction of Apoptosis Cancer Res., September 15, 2004; 64(18): 6603 - 6609. [Abstract] [Full Text] [PDF]

				T. Kuwasaki, M. Hatta, H. Takeuchi, and H. Takaku Inhibition of human immunodeficiency virus 1 replication in vitro by a self-stabilized oligonucleotide with 2'-O-methyl-guanosine-uridine quadruplex motifs J. Antimicrob. Chemother., April 1, 2003; 51(4): 813 - 819. [Abstract] [Full Text] [PDF]

				J. Vercammen, G. Maertens, M. Gerard, E. De Clercq, Z. Debyser, and Y. Engelborghs DNA-induced Polymerization of HIV-1 Integrase Analyzed with Fluorescence Fluctuation Spectroscopy J. Biol. Chem., October 4, 2002; 277(41): 38045 - 38052. [Abstract] [Full Text] [PDF]

				A. Siddiqui-Jain, C. L. Grand, D. J. Bearss, and L. H. Hurley Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription PNAS, September 3, 2002; 99(18): 11593 - 11598. [Abstract] [Full Text] [PDF]

				J.-i. Suzuki, N. Miyano-Kurosaki, T. Kuwasaki, H. Takeuchi, G. Kawai, and H. Takaku Inhibition of Human Immunodeficiency Virus Type 1 Activity In Vitro by a New Self-Stabilized Oligonucleotide with Guanosine-Thymidine Quadruplex Motifs J. Virol., February 22, 2002; 76(6): 3015 - 3022. [Abstract] [Full Text] [PDF]

				W. Pluymers, N. Neamati, C. Pannecouque, V. Fikkert, C. Marchand, T. R. Burke Jr., Y. Pommier, D. Schols, E. De Clercq, Z. Debyser, et al. Viral Entry as the Primary Target for the Anti-HIV Activity of Chicoric Acid and Its Tetra-Acetyl Esters Mol. Pharmacol., September 1, 2000; 58(3): 641 - 648. [Abstract] [Full Text]

				N. Jing, E. De Clercq, R. F. Rando, L. Pallansch, C. Lackman-Smith, S. Lee, and M. E. Hogan Stability-Activity Relationships of a Family of G-tetrad Forming Oligonucleotides as Potent HIV Inhibitors. A BASIS FOR ANTI-HIV DRUG DESIGN J. Biol. Chem., February 4, 2000; 275(5): 3421 - 3430. [Abstract] [Full Text] [PDF]

				T. L. Wallace, C. Gamba-Vitalo, K. S. Loveday, and P. A. Cossum Acute, Multiple-Dose, and Genetic Toxicology of AR177, an Anti-HIV Oligonucleotide Toxicol. Sci., January 1, 2000; 53(1): 63 - 70. [Abstract] [Full Text] [PDF]

				Z. Gu, M. A. Wainberg, N. Nguyen-Ba, L. L'Heureux, J.-M. de Muys, T. L. Bowlin, and R. F. Rando Mechanism of Action and In Vitro Activity of 1',3'-Dioxolanylpurine Nucleoside Analogues against Sensitive and Drug-Resistant Human Immunodeficiency Virus Type 1 Variants Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2376 - 2382. [Abstract] [Full Text]

				N. Jing and M. E. Hogan Structure-Activity of Tetrad-forming Oligonucleotides as a Potent Anti-HIV Therapeutic Drug J. Biol. Chem., December 25, 1998; 273(52): 34992 - 34999. [Abstract] [Full Text] [PDF]

				V. Balasubramanian, L. T. Nguyen, S. V. Balasubramanian, and M. Ramanathan Interferon-gamma -Inhibitory Oligodeoxynucleotides Alter the Conformation of Interferon-gamma Mol. Pharmacol., May 1, 1998; 53(5): 926 - 932. [Abstract] [Full Text]

				J. A. Esté, C. Cabrera, D. Schols, P. Cherepanov, A. Gutierrez, M. Witvrouw, C. Pannecouque, Z. Debyser, R. F. Rando, B. Clotet, et al. Human Immunodeficiency Virus Glycoprotein gp120 as the Primary Target for the Antiviral Action of AR177 (Zintevir) Mol. Pharmacol., February 1, 1998; 53(2): 340 - 345. [Abstract] [Full Text]

				P. Cherepanov, J. A. Esté, R. F. Rando, J. O. Ojwang, G. Reekmans, R. Steinfeld, G. David, E. De Clercq, and Z. Debyser Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1 Mol. Pharmacol., November 1, 1997; 52(5): 771 - 780. [Abstract] [Full Text]

				T. L. Wallace, S. A. Bazemore, K. Holm, P. M. Markham, J. P. Shea, N. Chaudhary, and P. A. Cossum Pharmacokinetics and Distribution of a 33P-labeled Anti-Human Immunodeficiency Virus Oligonucleotide (AR177) after Single- and Multiple-Dose Intravenous Administration to Rats J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1480 - 1488. [Abstract] [Full Text]

				J. S. Bishop, J. K. Guy-Caffey, J. O. Ojwang, S. R. Smith, M. E. Hogan, P. A. Cossum, R. F. Rando, and N. Chaudhary Intramolecular G-quartet Motifs Confer Nuclease Resistance to a Potent Anti-HIV Oligonucleotide J. Biol. Chem., March 8, 1996; 271(10): 5698 - 5703. [Abstract] [Full Text] [PDF]

				N. Jing, C. Marchand, J. Liu, R. Mitra, M. E. Hogan, and Y. Pommier Mechanism of Inhibition of HIV-1 Integrase by G-tetrad-forming Oligonucleotides in Vitro J. Biol. Chem., July 7, 2000; 275(28): 21460 - 21467. [Abstract] [Full Text] [PDF]